Industry News

Molina Healthcare, Inc. today announced that Britt Travis has joined the Company as its new vice president of Medicare sales. In this role, Travis will be responsible for Molina’ s sales operations, overseeing the distribution strategy and execution as well as channel development and management in the states in which the Company offers its Medicare products. Previously, Travis served as the vice president of distribution and sales at Highmark, Inc., a top-10..."/>
Molina Healthcare Names Britt Travis as Vice President of Medicare Sales
ContraFect Corporation, a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced the following organizational changes effective October 1, 2016.. Cara Cassino, M. D. has been promoted to Chief Medical Officer and Executive Vice President of Research and Development. She will provide leadership to all research and development..."/>
ContraFect Announces Organizational Changes
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products to improve the quality of life, today announces extension of 3,429,167 warrants that are to expire on September 26, 2016 by 18 months to March 26, 2018. The exercise price of the warrants will also increase from $0.10 to $0.16. About Quest PharmaTech Inc. Quest PharmaTech is a publicly traded, Canadian based pharmaceutical company developing products to..."/>
Quest PharmaTech Inc. Amends Warrant Terms
Leatt Corporation announced today that it will present at the inaugural MicroCap Leadership Summit, hosted by MicroCapClub, LLC, on Friday, September 23, 2016, at the Westin Chicago Northwest Hotel in Itasca, Illinois. The Company will present to approximately 50-60 retail and institutional microcap investors throughout the day using the summit's small group format. The Leatt presentation will be made by CEO, Sean Macdonald and..."/>
Leatt to Present at the MicroCap Leadership Summit
Valeant Pharmaceuticals International, Inc. seeks to clarify statements made in a media report today. Pursuant to a recommendation from our Patient Access and Pricing Committee, Valeant announced in May 2016 that an enhanced discount and rebate program for Nitropress and Isuprel would be made available to all hospitals in the United States. Under the enhanced program, all hospitals are eligible for a rebate of at least 10%, with rebates..."/>
Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel
Valeant Pharmaceuticals International, Inc. seeks to clarify statements made in a media report today. Pursuant to a recommendation from our Patient Access and Pricing Committee, Valeant announced in May 2016 that an enhanced discount and rebate program for Nitropress and Isuprel would be made available to all hospitals in the United States. Under the enhanced program, all hospitals are eligible for a rebate of at least 10%, with rebates totaling..."/>
Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel
Molina Healthcare, Inc. today announced that it has completed its previously announced offer to exchange up to $700 million aggregate principal amount of its 5.375% Senior Notes due 2022 and the note guarantees associated therewith issued on November 10, 2015, in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended, with up to an equal aggregate principal amount of its 5.375% Senior Notes due 2022 and..."/>
Molina Healthcare Announces Completion of Offer to Exchange Its Privately Placed 5.375% Senior Notes Due 2022 With Registered 5.375% Senior Notes Due 2022
Exact Sciences Corp. today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 24,119 shares of common stock to 18 recently hired non-executive employees under its previously announced inducement grant program. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date. The awards were granted as an..."/>
Exact Sciences Grants Inducement Restricted Stock Unit Awards to Recently Hired Employees
Dynatronics Corporation today announced that it will present at the Annual Ladenburg Thalmann Healthcare Conference at the Sofitel Hotel in New York City. Kelvyn H. Cullimore, Jr., Chairman and President, is scheduled to present to leading institutional investment representatives on Tuesday, September 27 at 3:00 PM EDT. The Ladenburg Thalmann Conference showcases leading-edge companies in the healthcare arena."/>
Dynatronics to Participate in Ladenburg Thalmann's Healthcare Conference
IntelGenx Technologies Corp. announced today that the Company's Board of Directors granted options to acquire a total of 650,000 common shares under the 2016 Stock Option Plan. Of the total stock options granted, 200,000 were granted to Dana Matzen, the Vice President, Business and Corporate Development of IntelGenx Corp. and 75,000 were granted to Mark Nawacki, a non employee Director of the Company. In addition, a total of 325,000 options to..."/>
IntelGenx Grants Stock Options
TeamHealth Holdings, Inc. has acquired provider operations of Bay City, Michigan-based medical management company EmMed, PC, the company said. EmMed, PC provides care to approximately 44,000 patients each year through staffing and management of the emergency department at McLaren Bay Regional Hospital. Team Health Holdings provides outsourced healthcare professional staffing and administrative..."/>
TeamHealth Acquires Provider Operations of Medical Management Firm EmMed
Dechra Pharmaceuticals plc has agreed to acquire the business and assets of Australia- and New Zealand-based veterinary pharmaceutical company Apex Laboratories Pty Ltd, the company said. The total consideration for the acquisition, which is expected is to complete on 14 October 2016, is USD 41.14 m. This will be funded from the group's own cash and debt resources."/>
Dechra Pharma to Acquire Australian Veterinary Drugmaker Apex Laboratories for USD 41.14m
Mednax has acquired two new physician groups, in Naples and in Florence, S.C., the company announced Friday. Mednax said the transactions were for cash, but the purchase prices were not disclosed. These acquisitions make 12 physician group practices that Mednax has acquired so far this year."/>
BRIEF: Mednax acquires physician groups in Florida, S. Carolina [Sun Sentinel]
Quorum Health Corporation in the U.S. District Court for the Middle District of Tennessee. The complaint is brought on behalf of all purchasers of Quorum securities between May 2, 2016 and August 10, 2016, for alleged violations of the Securities Exchange Act of 1934 by Quorum's officers and directors."/>
Robbins Arroyo LLP: Quorum Health Corporation (QHC) Misled Shareholders According to a Recently Filed Class Action
Laboratory Corporation of America ® Holdings, announced the commencement of cash tender offers for any and all of the outstanding 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018 issued by Sequenom. There are currently outstanding $45 million in aggregate principal amount of the 2017 Notes and $85 million in aggregate principal amount of the 2018 Notes."/>
LabCorp Subsidiary Sequenom Inc. Announces Tender Offers and Consent Solicitations for 5% Convertible Senior Notes Due 2017 and 5% Convertible Senior Exchange Notes Due 2018
American Renal Associates Holdings, Inc. between April 20, 2016 and August 18, 2016, inclusive, and/or pursuant or traceable to American Renal’ s false and misleading Registration Statement and Prospectus issued in connection with the Company’ s initial public offering of..."/>
ARA INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against American Renal Associates Holdings, Inc.
NeuroMetrix, Inc. today announced that the Company’ s Quell ® Wearable Pain Relief Technology™ has won the Electronics Retailer Association Moxie Award for the Best Health Show 2016. This Moxie award recognizes the year’ s best direct response television campaigns. “We are proud that Quell advertising was recognized with the prestigious Moxie award,” said Frank McGillin, Senior Vice President and General Manager, Consumer.“ Quell is a breakthrough for the 100..."/>
NeuroMetrix Wins Electronics Retailer Association Award for Quell TV Advertising
Akari Therapeutics, an emerging growth, clinical-stage biopharmaceutical company, announced that Dr. Gur Roshwalb, Chief Executive Officer, will present at two upcoming investor conferences:. Ladenburg Thalmann 2016 Healthcare Conference in New York City on Tuesday, September 27, 2016 at 12:00 pm ET."/>
Akari Therapeutics to Present at Upcoming Investor Conferences on September 27 and 28 in New York City
Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending that IBRANCE be granted marketing authorization in the European Union for the treatment of women with hormone receptor-positive, human epidermal growth factor receptor 2- negative locally advanced or metastatic breast cancer. The CHMP's positive opinion is for IBRANCE to be used in combination with an..."/>
Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe
Pfizer Inc. today announced that a Phase 3 study of ertugliflozin, an investigational oral SGLT2 inhibitor for the treatment of patients with type 2 diabetes, met its primary endpoint."/>
Merck and Pfizer Announce Investigational Ertugliflozin Met Primary Endpoint of A1C Reduction When Added to Sitagliptin and Metformin in People with Type 2 Diabetes
Cellceutix Corporation,, a clinical stage biopharmaceutical company developing innovative therapies with dermatology, oncology, antibiotic, and anti-inflammatory applications, is pleased to announce today the appointment of LaVonne Lang, DrPH, to the role of Vice President, Regulatory Affairs. Lang has over twenty-five years of experience in a variety of specialty roles with a focus in several different therapeutic areas in pharmaceutical..."/>
Cellceutix Announces Appointment of Vice President for Regulatory Affairs

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology717 Articles
Consumer Discretionary599 Articles
Financials446 Articles
Industrials392 Articles
Health Care386 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.